TP53 and lung carcinoma: The distribution of the three genotypes of TP53, Arg/Arg, Arg/Pro, and Pro/Pro was found 36.67%, 56.11% and 7.22% in lung cancer patients compared to 37%, 58% and 5% in healthy control respectively (Table 2).